Angelina I. Londoño

Molecular Response to Neoadjuvant Chemotherapy in High-Grade Serous Ovarian Carcinoma

Rebecca C. Arend, Angelina I. Londoño, Allison M. Montgomery et al. · Molecular Cancer Research · 2018 · 64 citations

Medicine, Molecular Genetics, Oncology +17

Epigenetic modifiers upregulate MHC II and impede ovarian cancer tumor growth

T.B. Turner, Selene Meza‐Perez, Angelina I. Londoño et al. · Oncotarget · 2017 · 55 citations · Full text

Medicine, Oncology, Pharmacology +17

Manipulating the Wnt/β-catenin signaling pathway to promote anti-tumor immune infiltration into the TME to sensitize ovarian cancer to ICB therapy

Jaclyn Wall, Selene Meza‐Perez, Carly Bess Scalise et al. · Gynecologic Oncology · 2020 · 50 citations · Full text

Medicine, Cancer Biology, Oncology +16

Inhibition of the Wnt/β-catenin pathway enhances antitumor immunity in ovarian cancer

David W. Doo, Selene Meza‐Perez, Angelina I. Londoño et al. · Therapeutic Advances in Medical Oncology · 2020 · 49 citations · Full text

Medicine, Immunology, Oncology +17

The antitumor effects of entinostat in ovarian cancer require adaptive immunity

Haller J. Smith, Tyler R. McCaw, Angelina I. Londoño et al. · Cancer · 2018 · 33 citations · Full text

Life Sciences, Immunology, Oncology +17